GlobalData on MSN3d
PharmaJet signs deal with Scancell for needle-free melanoma vaccineScancell is responsible for the clinical and regulatory development, as well as commercialisation of the combined product.
Doherty Clinical Trials is calling for healthy volunteers to participate in a phase one trial of the vaccines to assess the ...
PharmaJet and Scancell agreement builds on PharmaJet's strategy to be the best-in-class delivery system for novel DNA and RNA ...
The scheme lists a variety of recognised adverse health conditions that have been found to have resulted in some people as a ...
Vaxxas today announced that it has initiated a multi-center Phase I clinical trial of a vaccine against pre-pandemic avian ...
A tiny skin patch half the size of a postage stamp is about to be tested in Melbourne to see if it can safely deliver a ...
PharmaJet has signed a deal with Scancell Holdings to use its needle-free delivery system, Stratis, to deliver Scancell’s advanced melanoma DNA vaccine (Immunobody SCIB1/iSCIB1+). Under the ...
The PharmaJet Needle-free Delivery System has shown effective uptake of the SCIB1 DNA vaccine in addition to offering speed, convenience, and enhanced patient experience. PharmaJet is eligible to ...
LONDON (Reuters) -Bavarian Nordic said on Thursday its mpox vaccine was approved by the EU's drug regulator for use in ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback